cytarabine has been researched along with Rheumatoid Arthritis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksamit, AJ; Deen, HG; Dickson, DW; Dominik, J; Freeman, WD; Rahmlow, M; Robles, HA; Shuster, EA | 1 |
| Boveri, E; Castagnola, C; Castello, A; Magrini, U | 1 |
| Kashyap, A; Snowden, J | 1 |
| Jones, RJ; Karp, JE; Roubenoff, R; Stevens, MB | 1 |
1 review(s) available for cytarabine and Rheumatoid Arthritis
| Article | Year |
|---|---|
Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Busulfan; Carmustine; Cyclophosphamide; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Melphalan; Podophyllotoxin; Radiotherapy, Adjuvant; Transplantation Conditioning; Transplantation, Autologous; Vidarabine | 2001 |
3 other study(ies) available for cytarabine and Rheumatoid Arthritis
| Article | Year |
|---|---|
Leflunomide-associated progressive multifocal leukoencephalopathy.
Topics: Arthritis, Rheumatoid; Biopsy; Brain; Cytarabine; Humans; Immunosuppressive Agents; Injections, Intravenous; Isoxazoles; Leflunomide; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Middle Aged; Seizures; Staining and Labeling | 2008 |
Aberrant phenotype of plasmacytoid monocytes in acute myeloid leukemia.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Bone Marrow; Cell Differentiation; Clone Cells; Cytarabine; Fatal Outcome; Humans; Idarubicin; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Megakaryocytes; Methotrexate; Middle Aged; Monocytes; Neoplasm Proteins; Neoplastic Stem Cells | 2008 |
Remission of rheumatoid arthritis with the successful treatment of acute myelogenous leukemia with cytosine arabinoside, daunorubicin, and m-AMSA.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Remission Induction | 1987 |